Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10960-10968
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10960
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10960
Table 4 Treatment-related toxicity
Grade I/II/III/IV | |||
GEM | CPT-11 | Doxorubicin | |
Aminotransferase elevation | 2/4/2/0 | 4/2/0/0 | 7/2/1/0 |
Hyperbilirubinemia | 1/0/0/0 | 1/0/0/0 | 2/0/0/0 |
Gastrointestinal toxicity | 1/0/0/0 | 2/0/0/0 | 0/1/0/0 |
Post-embolization symptom | 3/2/0/0 | 3/3/0/0 | 7/5/0/0 |
Bone marrow inhibition | 4/5/3/2 | 2/1/2/1 | 8/5/4/0 |
Diarrhea | 0/0/0/0 | 1/1/0/0 | 0/0/0/0 |
- Citation: Wu J, Song L, Zhao DY, Guo B, Liu J. Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2014; 20(31): 10960-10968
- URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10960.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i31.10960